Evaluating Increasing Physical Activity After Acute Coronary Syndrome
A Randomized, Controlled Trial Evaluating Methods to Use Physical Activity to Improve Outcomes After Acute Coronary Syndrome
1 other identifier
interventional
105
0 countries
N/A
Brief Summary
This study will use a randomized, controlled trial to test the effectiveness of a home-based physical activity program using wearable devices and financial incentives. All participants in will establish a baseline step count during the first two weeks and then proceed to a 16-week intervention period and 8-week follow-up period.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2016
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 19, 2015
CompletedFirst Posted
Study publicly available on registry
August 21, 2015
CompletedStudy Start
First participant enrolled
February 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 3, 2017
CompletedResults Posted
Study results publicly available
July 11, 2019
CompletedJuly 11, 2019
July 1, 2019
1 year
August 19, 2015
December 7, 2018
July 10, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Mean Daily Steps
The primary outcome variable is the change in mean daily step count from the baseline period to the maintenance period (weeks 9-16).
Baseline and end of Maintenance Period at Week 16
Secondary Outcomes (1)
Change in Mean Daily Steps From Baseline to Follow-up Period
Baseline and end of Follow Up Period at week 24
Study Arms (2)
Control
ACTIVE COMPARATORParticipants will be given standard exercise recommendations that are given to all patients based on the federal guidelines. They will monitor their step counts using a wearable device and receive daily feedback.
Intervention
EXPERIMENTALParticipants will be given a wearable device to monitor daily step counts with automated daily feedback on goal attainment via text message or email. A baseline step count will be calculated for each participant (weeks 1-2) and then they will be given a daily step goal with an increase of 15 percentage point each week during the 8-week ramp-up period (weeks 3-10) with a maximum goal of 10,000 steps. Then they'll be asked to maintain that step count (maintenance period). During the ramp-up and maintenance period they'll have a financial incentive of $14 allocated each week and $2 taken away each day the goal is not achieved. They'll be followed up for 8 weeks without incentives
Interventions
A daily financial incentive framed as a loss of $2 each day goal is not acheived
Daily feedback from an activity tracking device worn on the wrist to track step counts and sleep patterns
Eligibility Criteria
You may qualify if:
- Age ≥18 years;
- ability to read and provide informed consent to participate in the study;
- History of a) acute coronary syndrome (unstable angina, non-ST segment elevation myocardial infarction or ST segment elevation myocardial infarction); or b) patients having undergone coronary catheterization for suspected coronary artery disease.
You may not qualify if:
- Inability to provide informed consent;
- does not have daily access to a smartphone compatible with the wearable device;
- unable or unwilling to complete the baseline 6-minute walk test and return to perform the 6-minute walk test at 10 and 18 weeks;
- already enrolled in an exercise cardiac rehabilitation program prior to hospital admission;
- hemodynamic instability or New York Heart Association III-IV heart failure;
- any other medical conditions that would prohibit participation in an 18-week physical activity program;
- not being discharged to home if recently admitted.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (2)
Fortunato M, Adusumalli S, Chokshi N, Harrison J, Rareshide C, Patel M. Usability of Wearable Devices to Remotely Monitor Sleep Patterns Among Patients With Ischemic Heart Disease: Observational Study. JMIR Form Res. 2020 Apr 7;4(4):e14508. doi: 10.2196/14508.
PMID: 32254044DERIVEDChokshi NP, Adusumalli S, Small DS, Morris A, Feingold J, Ha YP, Lynch MD, Rareshide CAL, Hilbert V, Patel MS. Loss-Framed Financial Incentives and Personalized Goal-Setting to Increase Physical Activity Among Ischemic Heart Disease Patients Using Wearable Devices: The ACTIVE REWARD Randomized Trial. J Am Heart Assoc. 2018 Jun 13;7(12):e009173. doi: 10.1161/JAHA.118.009173.
PMID: 29899015DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Limitations and Caveats
Patients were from 4 hospitals in Southeastern Pennsylvania and had to use a smartphone or tablet. Physical activity measures were limited to only step counts.
Results Point of Contact
- Title
- Dr. Mitesh S. Patel
- Organization
- Perelman School of Medicine, University of Pennsylvania
Study Officials
- PRINCIPAL INVESTIGATOR
Mitesh Patel, MD, MBA, MS
University of Pennsylvania
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 19, 2015
First Posted
August 21, 2015
Study Start
February 1, 2016
Primary Completion
February 1, 2017
Study Completion
April 3, 2017
Last Updated
July 11, 2019
Results First Posted
July 11, 2019
Record last verified: 2019-07
Data Sharing
- IPD Sharing
- Will not share